Gall Matthew

Average Profitability
9.8%
Insider Buys Quantity
3
Insider Buys Sum
$210,931.50
Insider Sells Quantity
1
Insider Sells Sum
$232,250.00

Insider Activity of Gall Matthew

According to the SEC Form 4 filings, Gall Matthew, being in a position of

  1. Chief Financial Officer at iTeos Therapeutics, Inc.,
    оver the last 12 months, has bought 5000 shares for $38,635, and sold 0 shares,
    over all time since 2021-06-16, has bought 15000 shares for $210,932, and sold 5000 shares for $232,250.

The largest purchase of all time was on 2021-06-16 and amounted to 5000 shares of iTeos Therapeutics, Inc. for $130,447.

The largest sale of all time was on 2021-12-27 and amounted to 5000 shares of iTeos Therapeutics, Inc. for $232,250.

Biography of Gall Matthew

No biography is available at this moment.

2024-11-19PurchaseiTeos Therapeutics, Inc.
ITOS
Chief Financial Officer
5,000
0.0135%
$7.73$38,635+1.33%
2023-10-12PurchaseiTeos Therapeutics, Inc.
ITOS
Chief Financial Officer
5,000
0.0136%
$8.37$41,850+28.59%
2021-12-27SaleiTeos Therapeutics, Inc.
ITOS
Chief Financial Officer
5,000
0.0141%
$46.45$232,250-50.28%
2021-06-16PurchaseiTeos Therapeutics, Inc.
ITOS
Chief Financial Officer
5,000
0.0143%
$26.09$130,447+9.8%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.